Accretive Health
AH
AH was delisted on the 14th of March, 2014.
6 hedge funds and large institutions have $11.8M invested in Accretive Health in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding
Funds holding: 6 → 6 (0)
50% less capital invested
Capital invested by funds: $23.4M → $11.8M (-$11.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
+$1.03M |
| 2 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$39.4K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$214 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
-$22.6K |
| 2 |
RMC
Regis Management Company
Menlo Park,
California
|
-$4.96K |
AH Hedge Fund Activity: Q3 2015 in Review
6 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q3 2015, worth a combined $11.8M — down 50% from $23.4M a quarter earlier.
Fund positioning in AH was balanced in Q3 2015: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was GMT Capital, adding an estimated $1.03M. The largest seller was Neuberger Berman Group, cutting an estimated $22.6K.
- 6 institutional investors held Accretive Health (AH) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $11.8M of Accretive Health stock for Q3 2015, down 50% quarter-over-quarter.
- 0 funds opened new Accretive Health positions in Q3 2015 and 0 closed out.
- The largest Accretive Health buyer in Q3 2015 was GMT Capital, an estimated $1.03M added.
- The largest Accretive Health seller in Q3 2015 was Neuberger Berman Group, an estimated $22.6K sold.
Based on aggregated 13F filings for Q3 2015.